Global HLA Typing Services Market Growth (Status and Outlook) 2024-2030

Global HLA Typing Services Market Growth (Status and Outlook) 2024-2030

Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.

The global HLA Typing Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “HLA Typing Services Industry Forecast” looks at past sales and reviews total world HLA Typing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected HLA Typing Services sales for 2023 through 2029. With HLA Typing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HLA Typing Services industry.

This Insight Report provides a comprehensive analysis of the global HLA Typing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HLA Typing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HLA Typing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HLA Typing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HLA Typing Services.

United States market for HLA Typing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for HLA Typing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for HLA Typing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key HLA Typing Services players cover Novogene, Abace Biology, Illumina, IGE Bio, CapitalBio Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of HLA Typing Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Serotyping
DNA Typing

Segmentation by Application:
Clinical
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Serotyping
DNA Typing

Segmentation by Application:
Clinical
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novogene
Abace Biology
Illumina
IGE Bio
CapitalBio Technology
Thermo Fisher Scientific
TBG Diagnostics
ProImmune
CD Genomics
CareDx
Creative Biolabs
Cellecta
GenDx

Please note: The report will take approximately 2 business days to prepare and deliver.